Lights EU

Lights EU Lights EU Lights EU Lights EU Lights EU Lights EU Lights EU Lights EU Lights EU Lights EU Lights EU Lights EU Lights EU Lights EU Lights EU Lights EU Lights EU Lights EU Lights EU Lights EU Lights EU Lights EU Lights EU Lights EU


		The project is clearly oriented to directly halt the progression of ovarian cancer and interfere with the development of drug resistance upon treatment with platinum-derived drugs by inhibiting the protein regulatory function of monomeric TS. The intermediate objectives are based on employing novel medicinal chemistry strategies to identify potential drug candidates with new mechanisms of action.

info@lights-eu.org

MANAGEMENT

Coordination
Committee
Guest scientists
Participants

Synopsis
Project summary

WORK PACKAGES

PROJECT MEETINGS


	LIGands to interfere with Human TS - LIGHTS is a STREP project within the 6FP. Lights is focused on ovarian cancer and carried out by a consortium of six partners: University of Modena and Reggio Emilia (I) - University di Paris Sud (FR) European Media Laboratories (D) - Molecular Discovery (I) - Naxospharma (I) - University of California San Francisco (UCSF)
	Realized by Newlogic